A new clinical study published in the International Journal of Gynecological Cancer reports encouraging results for women ...

A new study co-written by a University of Illinois Urbana-Champaign expert in operations management finds that drugs approved ...

While online coaching improves asthma management short-term, it does not sustain physical activity changes, highlighting the ...

The third-line results build on equally compelling second-line data, where pelareorep achieved a 30% response rate, more than doubling the 13.8% benchmark for the only FDA-approved immunotherapy in ...

In a small pilot study of patients with advanced pancreatic cancer, early access to medical cannabis shows promise in the ...

With Moleculin’s WP1066 oral formulation, an externally funded Phase 2 trial in combination with radiation treating GBM, a form of brain cancer, is recruiting and treating subjects at Northwestern ...

Adding yoga to standard treatment for opioid use disorder is associated with faster recovery from opioid withdrawal symptoms.

FDA written feedback supports:- a single-arm, open-label registrational trial in 2nd-line refractory high-grade NMIBC with CIS- a randomized vs ...

ORKA-002 interim Phase 1 data demonstrates a half-life of 75-80 days supporting potential for twice-per-year dosing in ...

Summit Therapeutics Inc. (NASDAQ: SMMT) today announced it has entered into a clinical trial collaboration with GSK plc ("GSK ...